Yuanjie Niu

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Shimiao Zhu, Zheng Zhang, Hui Zhang, Zihao Liu, Min Liu, Qing Liu, Li Zang, Lili Wang, Junpeng Ji, Bo Wu, Libin Sun, Zhenting Zhang, Heran Cao, Yong Wang, Haitao Wang, Zhiqun Shang, Yuanjie Niu
DNA-repair status should be assessed in treatment-emergent neuroendocrine prostate cancer before platinum-based therapy. The Prostate 82 (4) (2022)

Yuanjie Niu.css-eqlu8i{font-size:small;padding-left:4px;}